Expression, purification and characterization of factor IX derivatives using a novel vector system

Protein Expression and Purification

Volumn 50, Issue 2, 2006, Pages 196-202

  Yang, Likui ^a   Gopalakrishna, Kota ^a   Manithody, Chandrashekhara ^a   Rezaie, Alireza R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Epitope tagging; Factor IXa; Factor X; Intrinsic Xase; Mutagenesis; Sodium

Indexed keywords

ALANINE; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; CALCIUM; CANCER PROCOAGULANT; CYSTEINE PROTEINASE; RECOMBINANT PROTEIN; SODIUM; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CATALYSIS; CHEMICAL STRUCTURE; ENZYME ACTIVATION; GENE VECTOR; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MUTATION; PLASMID; PROTEIN BINDING; PROTEIN CONFORMATION;

ALANINE; CALCIUM; CATALYSIS; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; FACTOR IXA; FACTOR VIIIA; FACTOR X; GENETIC VECTORS; HUMANS; MODELS, MOLECULAR; MUTATION; NEOPLASM PROTEINS; PLASMIDS; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SODIUM;

MAMMALIA;

EID: 33750832581     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.05.012     Document Type: Article

References (36)

1. Bode W., Mayr I., Baumann U., Huber R., Stone S.R., and Hofsteenge J. The refined 1.9 Å crystal structure of human α-thrombin: interaction with d-Phe-Pro-Arg chlorometheylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 8 (1989) 3467-3475
2. Mann K.G., Jenny R.J., and Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu. Rev. Biochem. 57 (1988) 915-956
3. Furie B., and Furie B.C. The molecular basis of blood coagulation. Cell 53 (1988) 505-518
4. Davie E.W., Fujikawa K., and Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry 30 (1991) 10363-10370
5. Yoshitake S., Schach B.G., Foster D.C., Davie E.W., and Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 24 (1985) 3736-3750
6. Thompson A.R. Structure, function, and molecular defects of factor IX. Blood 67 (1986) 565-572
7. Kurachi K., and Davie E.W. Isolation and characterization of a cDNA coding for human factor IX. Proc. Natl. Acad. Sci. USA 79 (1982) 6461-6464
8. Osterud B., and Rapaport S.I. Activation of factor IX by the reaction product of tissue factor and factor VII: an additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. USA 74 (1977) 5260-5264
9. Lindquist P.A., Fujikawa K., and Davie E.W. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom. J. Biol. Chem. 253 (1978) 1902-1909
10. Hamaguchi N., Charifson P.S., Pedersen L.G., Brayer G.D., Smith K.J., and Stafford D.W. Expression and characterization of human factor IX. J. Biol. Chem. 266 (1991) 15213-15220
11. Stenflo J. Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. Blood 78 (1991) 1637-1651
12. Mertens K., Celie P.H.N., Kolkman J.A., and Lenting P.J. Factor VIII-factor IX interactions: molecular sites involved in enzyme-cofactor complex assembly. Thromb. Haemost. 82 (1999) 209-217
13. Wilkinson F.H., Ahmad S.S., and Walsh P.N. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex. J. Biol. Chem. 277 (2002) 5734-5741
14. Blostein M.D., Furie B.C., Rajotte I., and Furie B. The Gla domain of factor IXa binds to factor VIIIa in the tenase complex. J. Biol. Chem. 278 (2003) 31297-31302
15. Hopfner K.-P., Lang A., Karcher A., Sichler K., Kopetzki E., Brandstetter H., Huber R., Bode W., and Engh R.A. Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding. Structure 7 (1999) 989-996
16. Mutucumarana V.P., Duffy E.J., Lollar P., and Johnson A.E. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa: a fluorescence study. J. Biol. Chem. 267 (1992) 17012-17021
17. Wilkinson F.H., London F.S., and Walsh P.N. Residues 88-109 of factor IXa are important for assembly of factor X activating complex. J. Biol. Chem. 277 (2002) 5725-5733
18. Sichler K., Kopetzki E., Huber R., Bode W., Hopfner K.-P., and Brandstetter H. Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop. J. Biol. Chem. 278 (2003) 4121-4126
19. Chang J., Jin J., Lollar P., Bode W., Brandstetter H., Hamaguchi N., Straight D.L., and Stafford D.W. Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity. J. Biol. Chem. 273 (1998) 12089-12094
20. Bode W., and Schwager P. The refined crystal structure of bovine beta-trypsin at 1.8 Å resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. J. Mol. Biol. 98 (1975) 693-717
21. Guinto E.R., Caccia S., Rose T., Futterer K., Waksman G., and Di Cera E. Unexpected crucial role of residue 225 in serine proteases. Proc. Natl. Acad. Sci. USA 96 (1999) 1852-1857
22. +-induced allosteric regulation of catalytic activity in serine proteases. Proc. Natl. Acad. Sci. USA 93 (1996) 10653-10656
23. He X., and Rezaie A.R. Identification and characterization of the sodium-binding site of activated protein C. J. Biol. Chem. 274 (1999) 4970-4976
24. Rezaie A.R., and He X. Sodium binding site of factor Xa: role of sodium in the prothrombinase complex. Biochemistry 39 (2000) 1817-1825
25. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
26. Prasad S., Wright K.L., Banerjee Roy D., Bush L.A., Cantwell A.M., and Di Cera E. Redesigning the monovalent cation specificity of an enzyme. Proc. Natl. Acad. Sci. USA 100 (2003) 13785-13790
27. + and factor Va in the prothrombinase complex. J. Biol. Chem. 279 (2004) 48262-48269
28. Leytus S.P., Foster D.C., Kurachi K., and Davie E.W. Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 25 (1986) 5098-5102
29. 2+ binding to both antigen and antibody. J. Biol. Chem. 263 (1988) 826-832
30. Rezaie A.R., Fiore M.M., Neuenschwander P.F., Esmon C.T., and Morrissey J.H. Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Expr. Purif. 3 (1992) 453-460
31. Manithody C., Yang L., and Rezaie A.R. Role of basic residues of the autolysis loop in the catalytic function of factor Xa. Biochemistry 41 (2002) 6780-6788
32. Chen L., Manithody C., Yang L., and Rezaie A.R. Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci. 13 (2004) 431-442
33. Smirnov M.D., and Esmon C.T. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J. Biol. Chem. 269 (1994) 816-819
34. Yang L., Manithody C., and Rezaie A.R. Localization of the heparin binding exosite of factor IXa. J. Biol. Chem. 277 (2002) 50756-50760
35. Jenkins P.V., Freas J., Schmidt K.M., Zhou Q., and Fay P.J. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex. Blood 100 (2002) 501-508
36. Yang L., Manithody C., Olson S.T., and Rezaie A.R. Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa. J. Biol. Chem. 278 (2003) 25032-25038